- cafead   Jun 17, 2021 at 12:22: PM
via Sanofi and Regeneron’s asthma and eczema drug climbed back to No. 1 in May, while AbbVie’s blockbuster anti-inflammatory dropped again to second, according to data from real-time TV ad tracker iSpot.tv.
article source
article source